Please be aware that we may update information relating to this company/topic at any time, and updates will be available for purchase as a new report. If you are interested in obtaining access to all of our reports and all report updates, we also have a quarterly subscriptions available. Please contact for information about our subscription plans.
Purchase 1 report for $99 or 3 reports for $249.
Emergent BioSolutions(EBS) is a global specialty life science company that develops and commercializes vaccines, drugs and devices that address biodefense threats. The Company is preferred provider of biodefense products and servies to the U.S. government under multi-year contracts. It's most valuable product, BioThrax is the only FDA-approved antrax vaccine. The Company's products are sold mainly in the U.S. as well as internationally.